179 related articles for article (PubMed ID: 19208889)
1. Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease.
Malkin J; Shrimpton A; Wiselka M; Barer MR; Duddridge M; Perera N
J Med Microbiol; 2009 Mar; 58(Pt 3):371-373. PubMed ID: 19208889
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium kansasii olecranon bursitis.
Barham GS; Hargreaves DG
J Med Microbiol; 2006 Dec; 55(Pt 12):1745-1746. PubMed ID: 17108281
[TBL] [Abstract][Full Text] [Related]
3. Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.
Cosson MA; Bertrand JB; Martin C; Veziris N; Picard C; Goulvestre C; Coignard S; Benoit JP; Silvera S; Moro MR; Poyart C; Morand PC
J Med Microbiol; 2012 Nov; 61(Pt 11):1617-1620. PubMed ID: 22859583
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium kansasii arthritis of the elbow in an immunocompetent patient with a suspected soft-tissue tumor.
Okuno H; Tanaka H; Hagiya H; Yoshida H; Hamaguchi S; Hori Y; Morii E; Hamada K; Yoshikawa H; Tomono K
J Infect Chemother; 2020 Feb; 26(2):261-264. PubMed ID: 31427201
[TBL] [Abstract][Full Text] [Related]
5. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
[TBL] [Abstract][Full Text] [Related]
6. [Swelling of right knee in an immunologically compromised patient].
Cajigas-Pezo D; Lorenzo-Hernandez A; Vives-Rivero GR; Rentero-Martínez Z
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):481-2. PubMed ID: 22521279
[No Abstract] [Full Text] [Related]
7. Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
Hradilek P; Zeman D; Tudik I; Zapletalova O; Ulmann V
Mult Scler; 2014 Apr; 20(5):639-40. PubMed ID: 23959714
[No Abstract] [Full Text] [Related]
8. Failure of isoniazid chemoprophylaxis during infliximab therapy.
Fernández-Guerrero ML; Esteban J; Acebes C; Górgolas M
Emerg Infect Dis; 2007 Sep; 13(9):1428-9. PubMed ID: 18252132
[No Abstract] [Full Text] [Related]
9. Olecranon bursitis secondary to Mycobacterium europaeum infection in a patient receiving immunosuppressive drugs for rheumatoid arthritis.
Dutertre M; Delobel P; Marchou B; Boyer JF; Mougari F; Martin-Blondel G
Med Mal Infect; 2019 Aug; 49(5):358-359. PubMed ID: 31097371
[No Abstract] [Full Text] [Related]
10. [Pain, swelling, and progressive weakness of the left knee over 6 years].
Pelfort X; Horcajada JP; Puig L; Salvadó M
Enferm Infecc Microbiol Clin; 2008 Nov; 26(9):595-6. PubMed ID: 19100182
[No Abstract] [Full Text] [Related]
11. Cutaneous infection by Mycobacterium haemophilum and kansasii in an IgA-deficient man.
Bekou V; Büchau A; Flaig MJ; Ruzicka T; Hogardt M
BMC Dermatol; 2011 Jan; 11():3. PubMed ID: 21269422
[TBL] [Abstract][Full Text] [Related]
12. Severe sporotrichoid fish tank granuloma following infliximab therapy.
Rallis E; Koumantaki-Mathioudaki E; Frangoulis E; Chatziolou E; Katsambas A
Am J Clin Dermatol; 2007; 8(6):385-8. PubMed ID: 18039022
[TBL] [Abstract][Full Text] [Related]
13. [Fever and thin-walled cavitary lung lesions].
Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
[No Abstract] [Full Text] [Related]
14. [Disseminated disease by Mycobacterium kansasii resistant to isoniazid and rifampin in patients] with AIDS].
Ibarrola M; Baraia-Etxaburu J; Sánchez R; Teira R; Unzaga J; Miguel Santamaría J
Enferm Infecc Microbiol Clin; 2001 Feb; 19(2):80-2. PubMed ID: 11333577
[No Abstract] [Full Text] [Related]
15. A case of wrist tenosynovitis caused by Mycobacterium kansasii in a renal transplant recipient.
Chan A; Findlay A; Abeygunasekara S
Transpl Infect Dis; 2012 Oct; 14(5):E44-9. PubMed ID: 22822725
[TBL] [Abstract][Full Text] [Related]
16. Septic subacromial bursitis caused by Mycobacterium kansasii in an immunocompromised host.
Mathew SD; Tully CC; Borra H; Berven MD; Arroyo R
Mil Med; 2012 May; 177(5):617-20. PubMed ID: 22645893
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
Saleem N; Saba R; Maddika S; Weinstein M
Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629
[TBL] [Abstract][Full Text] [Related]
18. Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient.
Zhang M; Feng M; He JQ
Int J Infect Dis; 2017 Sep; 62():59-63. PubMed ID: 28712930
[TBL] [Abstract][Full Text] [Related]
19. Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.
Han SH; Kim KM; Chin BS; Choi SH; Lee HS; Kim MS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Kim JM
J Korean Med Sci; 2010 Feb; 25(2):304-8. PubMed ID: 20119588
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary
Padmapriyadarsini C; Nair D; Gomathi NS; Velayudham B
Indian J Med Microbiol; 2016; 34(4):516-519. PubMed ID: 27934834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
